Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial. [electronic resource]
Producer: 20030725Description: 9-16 p. digitalISSN:- 1522-8002
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Brain Neoplasms -- drug therapy
- Carmustine -- administration & dosage
- Ethanol
- Female
- Glioma -- drug therapy
- Humans
- Injections, Intralesional
- Magnetic Resonance Imaging
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Stereotaxic Techniques
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.